Fetal Bovine Serum Market Research Report – Forecast till 2030

Fetal Bovine Serum Market Research Report, by Product Type (Charcoal Stripped, Exosome Depleted, Stem Cell), by Application (Drug Discovery, Cell Culture Media, In-Vitro Fertilization), by End User (Pharmaceutical, Biotechnology)-Forecast Till 2030

ID: MRFR/HC/5908-HCR | August 2022 | Region: Global | 110 Pages         

Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Fetal Bovine Serum Market, by Product type

6.1 Overview

6.2 Charcoal Stripped

6.3 Chromatographic

6.4 Dialyzed Fetal Bovine Serum (FBS)

6.5 Exosome Depleted

6.6 Stem Cell

6.6.1 Embryonic Stem Cells Qualified

6.6.2 Mesenchymal Stem Cell Qualified

6.7 Others

Chapter 7. Global Fetal Bovine Serum Market, by Application

7.1 Overview

7.2 Drug Discovery

7.3 Cell Culture Media

7.4 In Vitro Fertilization

7.5 Human & Animal Vaccine Production

7.6 Diagnostics

7.7 Others

Chapter 8. Global Fetal Bovine Serum Market, by End User

8.1 Introduction

8.2 Research & Academic Institutes

8.3 Pharmaceutical

8.4 Biotech

8.5 Others

Chapter 9. Global Fetal Bovine Serum Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

Chapter 11. Company Profiles

11.1 HiMedia Laboratories

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Merck KGaA

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Bovogen Biologicals Pty Ltd

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Atlanta Biologicals Inc.

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 TCS Biosciences Ltd

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Tissue Culture Biologicals

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Rocky Mountain Biologicals

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 GE Healthcare

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Thermo Fisher Scientific

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Bio-Techne

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 PAN-Biotech

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Others

Chapter 12. Appendix

 

LIST OF TABLES

Table 1 Global Fetal bovine serum Market Synopsis, 2020-2027

Table 2 Global Fetal bovine serum Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)

Table 4 Global Fetal bovine serum Market, by Application, 2020-2027 (USD Million)

Table 5 Global Fetal bovine serum Market, by End User, 2020-2027 (USD Million)

Table 6 Global Fetal bovine serum Market, by Region, 2020-2027(USD Million)

Table 7 North America: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)

Table 8 North America: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)

Table 9 North America: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)

Table 10 North America: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)

Table 11 US: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)

Table 12 US: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)

Table 13 US: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)

Table 14 US: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)

Table 15 Canada: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)

Table 16 Canada: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)

Table 17 Canada: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)

Table 18 Canada: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)

Table 19 South America: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)

Table 20 South America: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)

Table 21 South America: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)

Table 22 South America: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)

Table 23 Europe: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)

Table 24 Europe: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)

Table 25 Europe: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)

Table 26 Europe: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)

Table 27 Western Europe: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)

Table 28 Western Europe: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)

Table 29 Western Europe: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)

Table 30 Western Europe: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)

Table 31 Eastern Europe: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)

Table 32 Eastern Europe: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)

Table 33 Eastern Europe: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)

Table 34 Eastern Europe: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)

Table 35 Asia-Pacific: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)

Table 36 Asia-Pacific: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)

Table 37 Asia-Pacific: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)

Table 38 Asia-Pacific: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)

Table 39 Middle East & Africa: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)

Table 40 Middle East & Africa: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)

Table 41 Middle East & Africa: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)

Table 42 Middle East & Africa: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Fetal bovine serum Market

Figure 3 Market Dynamics for Global Fetal bovine serum Market

Figure 4 Global Fetal bovine serum Market Share, by Product type, 2020 (%)

Figure 5 Global Fetal bovine serum Market Share, by Application, 2020 (%)

Figure 6 Global Fetal bovine serum Market Share, by End User, 2020 (%)

Figure 7 Global Fetal bovine serum Market Share, by Region, 2020 (%)

Figure 8 North America: Fetal bovine serum Market Share, by Country, 2020 (%)

Figure 9 Europe: Fetal bovine serum Market Share, by Country, 2020 (%)

Figure 10 Asia-Pacific: Fetal bovine serum Market Share, by Country, 2020 (%)

Figure 11 Middle East & Africa: Fetal bovine serum Market Share, by Country, 2020 (%)

Figure 12 Global Fetal bovine serum Market: Company Share Analysis, 2020 (%)

Figure 13 HiMedia Laboratories: Key Financials

Figure 14 HiMedia Laboratories: Segmental Revenue

Figure 15 HiMedia Laboratories: Geographical Revenue

Figure 16 Merck KGaA: Key Financials

Figure 17 Merck KGaA: Segmental Revenue

Figure 18 Merck KGaA: Geographical Revenue

Figure 19 Bovogen Biologicals Pty Ltd: Key Financials

Figure 20 Bovogen Biologicals Pty Ltd: Segmental Revenue

Figure 21 Bovogen Biologicals Pty Ltd: Geographical Revenue

Figure 22 Biomerics: Key Financials

Figure 23 Biomerics: Segmental Revenue

Figure 24 Biomerics: Geographical Revenue

Figure 25 TCS Biosciences Ltd: Key Financials

Figure 26 TCS Biosciences Ltd: Segmental Revenue

Figure 27 TCS Biosciences Ltd: Geographical Revenue

Figure 28 Tissue Culture Biologicals: Key Financials

Figure 29 Tissue Culture Biologicals: Segmental Revenue

Figure 30 Tissue Culture Biologicals: Geographical Revenue

Figure 31 Rocky Mountain Biologicals: Key Financials

Figure 32 Rocky Mountain Biologicals: Segmental Revenue

Figure 33 Rocky Mountain Biologicals: Geographical Revenue

Figure 34 GE Healthcare: Key Financials

Figure 35 GE Healthcare: Segmental Revenue

Figure 36 GE Healthcare: Geographical Revenue

Figure 37 Thermo Fisher Scientific: Key Financials

Figure 38 Thermo Fisher Scientific: Segmental Revenue

Figure 39 Thermo Fisher Scientific: Geographical Revenue

Figure 40 Bio-Techne: Key Financials

Figure 41 Bio-Techne: Segmental Revenue

Figure 42 Bio-Techne: Geographical Revenue

Figure 43 PAN-Biotech: Key Financials

Figure 44 PAN-Biotech: Segmental Revenue

Figure 45 PAN-Biotech: Geographical Revenue

Fetal Bovine Serum Market

The global fetal bovine serum market size was valued at is projected to reach USD 1,375.55 million at a CAGR of 5.6% from 2022 to 2030.

Segmentation

By Product Type Charcoal Stripped Exosome Depleted Stem Cell
By Application Drug Discovery Cell Culture Media In Vitro Fertilization
By End User Pharmaceutical Biotechnology

Key Players

  • HiMedia Laboratories
  • Merck KGaA
  • Bovogen Biologicals Pty Ltd
  • Atlanta Biologicals Inc.
  • TCS Biosciences Ltd
  • Tissue Culture Biologicals
  • Rocky Mountain Biologicals
  • GE Healthcare
  • Thermo Fisher Scientific
  • Bio-Techne
  • PAN-Biotech
  • Access Biologicals

Drivers

  • Increase In Demand From Traditional Users Of Serum
  • Higher Efficiency Rate Than Normal Blood Serum
Speak to Analyst Request a Free Sample

Fetal Bovine Serum Market Overview


The fetal bovine serum market share is expected to do good in the ongoing forecast period of 2020-2030. The market is likely to attain a global CAGR of 8.5% during the period and hence, reach a good market sum by the end of the period, as predicted by the business chiefs and industry experts.


Fetal bovine serum can be recognized as a type of by-product which is produced in the meat processing companies industries. The processes involve the use of several well-known applications that are employed especially in the pharmaceutical and biotechnology research industries. Fetal bovine serum is known to be attained from the whole blood of normal bovine fetuses. It is broadly used in an array of applications that are inclusive of some diagnostic systems and research studies.


COVID 19 Analysis of Fetal Bovine Serum Market


The fetal bovine serum market was gearing up for growth and was working on the strategies that will help the market dissolve the studied challenges for the market that will be ending in 2028. However, the sudden outbreak of the coronavirus pandemic has changed the total game for the market trends. The rising healthcare emergency is pushing people to alter their lifestyle and living methods so that they do not contract the infection which will deteriorate their condition. The rising fatalities and dangers that have been introduced because of the spread of the pandemic have resulted in the collapse of the global and established healthcare systems. The rising cases of the pandemic have led to the changing market trends and also, the global governments have been pushed to take important steps for the safety and healthcare of people.


However, the fetal bovine serum market is also witnessing a major need for the market to return to normalcy to maintain the market equilibrium between the demand and supply of the global market products and services. Also, the market is witnessing a reduced availability of investment and funds. The government and public sector along with the prominent players of the growing fetal bovine serum market size are collaborating to meet the investment needs that will help in fueling the growth of the market and cover the losses that have been incurred during the pandemic year of 2020.


Market Dynamics


Drivers


The fetal bovine serum market trends are witnessing a rapid increase in the degree of culture media consumption especially in the developing countries across the worldwide location which is emerging as one of the important factors intensifying the growth and thus, fetch a huge demand of fetal bovine serum market in the global market premises. In addition, the growing degree of demand from traditional users of serum is also known to be contributing to the growth in the global fetal bovine serum market over the forecast period of 2021 to 2028.


Restraints


However, the FBS report predicts that the market is likely to witness the growth of factors like the decrease in cattle herd population due to the increased demand for dairy and meat products. This factor holds the potential and is expected to restrain the fetal bovine serum market growth during the forecast period that is scheduled to be ending in 2028.


 Technology Analysis


The fetal bovine serum (FBS) market is on the rise to be witnessing a major degree of advancements and investment in the research activities followed by the rise in the academic initiatives by the private and governmental sector that is expected to drive the global fetal bovine serum market growth during the ongoing forecast period that is expected to be ending in 2028. Further, there has been a substantial increase in demand from traditional users of the market products and services like serum which is also expected to drive the growth of the market as per the predictions that have been laid down for the market. As the fetal bovine serum is known to have a higher degree of efficiency rate in comparison to the normal blood serum which is further, expected to boost the growth of the overall serum market during the period that ends in 2028. 


Study Objectives



  • The fetal bovine serum (FBS) market report has been curated to conduct a deep and meaningful market analysis and trends that are likely to prevail for the producers and manufacturers that are functioning in the global market premises to produce and manufacture goods and services to meet the rising needs of the target audience that is spread in various global locations.

  • The report aims to help market investors make their decisions by judging the profitability and expansion ratio for the fetal bovine serum market. The market report discusses the global trends along with the distribution of the market resources and raw materials that function in the form of market segments to meet the rising needs of the target audience. The report also helps to judge the potential of the market to perform well and meet the expected revenue figure that has been predicted for the market during the forecast period.

  • The report aims to discuss the fetal bovine serum market growth factors that will result in the emergence in the global degree of market competition that will have a major role in deciding the investment and funds that will be available for the market during the ongoing forecast period that is likely to end in 2028. The report also aims to have a basic understanding of the market operations and developments that will give rise to global competition in the industry during the forecast period. 


Segment Overview


The serum market size is known to be expanding during the current forecast period because of an excellent performance that has been recorded by the following fetal bovine serum market segments:


Based on the product type


The fetal bovine serum market is categorized into Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum (FBS), Exosome Depleted, Stem Cell, and others. Further, the stem cell segment of the market is divided into embryonic stem cells qualified, and mesenchymal stem cell qualified.


 Based on the market application


The fetal bovine serum market is segmented based on applications and includes drug discovery, cell culture media, in-vitro fertilization, human and animal vaccine production, diagnostics, amongst others. 


Based on the market end-users


The fetal bovine serum market is segmented based on the market end-users and includes research and academic institutes, pharmaceutical, biotechnology, and others. 


Regional Analysis


It is projected that the American region is likely to dominate the fetal bovine serum market. The main reason behind this is the growth of the market in the North American region. The growth is largely attributed to the rising market factors such as an increase in research funding, and growing awareness about the high-end fetal bovine serum among medical professionals.


 Also, the European region is currently holding a considerable amount of market share in the fetal bovine serum market. However, the region is predicted to undergo a declined growth due to ethical issues and religious sentiments.


 Competitive Landscape


The competitive players of the market are:



  • HiMedia Laboratories

  • Atlanta Biologicals Inc.

  • Merck KGaA

  • Bovogen Biologicals Pty Ltd

  • Tissue Culture Biologicals

  • TCS Biosciences Ltd

  • Rocky Mountain Biologicals

  • GE Healthcare 


Recent Developments



  • The global market trends support the functions undertaken by the rising number of contract research organizations along with a higher degree of growth of biopharmaceuticals and funding available from the government. These probable factors are also enhancing the growth of the markets amid the ongoing forecast period and hence, opening lucrative doors for the market in the global market.



  • There has been a huge degree of increase in the research and development activities in the global market that is dedicated towards the introduction of new biopharmaceuticals. This factor is likely to influence the rising demand patterns of fetal bovine serum, and therefore, will result in lifting the fetal bovine serum market growth in the above-mentioned forecast period. 



  • The has been a rapid degree of advancement in research and academic initiatives taken up by the various private and governmental sectors that will further accelerate the expansion of the fetal bovine serum market. Also, the global market players are offering significant growth opportunities for the market in the forecast period of 2021 to 2028. 


Intended Audience



  • Biopharmaceutical producers, manufacturers, and companies

  • Importers and export firms

  • Government institutions and public sector units

  • Retailers and dealers

  • Research and Development (R&D) companies

  • National laboratories

  • Market buyers

  • Product investors

  • Traders and wholesalers

  • Medical research laboratories


 Report Overview


The serum market report is likely to cover the major market aspects that will lead the market towards growth and attain the predicted trends of the market for the forecast period that will be ending in 2028. The fetal bovine serum market report discusses the functioning of the market segments and the recent developments that have been undertaken in the industry premises.



Report Scope:
Report Attribute/Metric Details
  Market Size   2030: Significant Value
  CAGR   2020-2030: 8.5%
  Base Year   2019
  Forecast Period   2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Application and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   HiMedia Laboratories, Merck KGaA, Bovogen Biologicals Pty Ltd, Atlanta Biologicals Inc., TCS Biosciences Ltd, Tissue Culture Biologicals, Rocky Mountain Biologicals, GE Healthcare, Thermo Fisher Scientific, Bio-Techne, PAN-Biotech, Access Biologicals, Animal Technologies Inc., Nucleus Biologics, Biological Industries, Corning Incorporated
  Key Market Opportunities   Research funding, and growing awareness about the high-end fetal bovine serum among medical professionals.
  Key Market Drivers

  • Advancement In Research And Academic Initiatives By The Private And Governmental Sector
  • Increase In Demand From Traditional Users Of Serum
  • Higher Efficiency Rate Than Normal Blood Serum


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Fetal bovine serum market is projected to grow at an 8.5% CAGR between 2020-2030.

    The Americas is expected to lead the fetal bovine serum market.

    Product shortage may limit the fetal bovine serum market.

    Major applications of the fetal bovine serum market include diagnostics, drug discovery, in-vitro fertilization, and others.